As COVID-19 continues to disrupt communities around the world, IVI remains committed to our mission to protect the world’s most vulnerable people from vaccine-preventable diseases by developing safe, effective, and affordable vaccines for global health. We do this for diseases like cholera and typhoid, as well as emerging infectious diseases.
An IVI lab scientist works on an antibody test in IVI’s labs in Seoul, Korea.
We’re very grateful to the government of Finland for committing funds to IVI and CEPI for COVID-19 vaccine development. The governments of South Korea, Sweden, and India also provide core funding to IVI that make our work possible. In unstable times, we’re grateful for these partnerships and proud to do our part in responding to the global health crisis we face today. Join us.